Report Detail

Request for Sample of this report

Service & Software Global Tumor Detection Services Market 2026 by Company, Regions, Type and Application, Forecast to 2032

  • RnM4733281
    • |
  • 24 August, 2026
    • |
  • Global
    • |
  • 128 Pages
    • |
  • GIR
    • |
  • Service & Software

According to our (Global Info Research) latest study, the global Tumor Detection Services market size was valued at US$ million in 2025 and is forecast to a readjusted size of US$ million by 2032 with a CAGR of %during review period.
Tumor detection services are medical services that aim to detect and diagnose cancer at an early stage through a series of medical examinations and tests. These services typically include imaging examinations (such as CT, MRI, ultrasound), laboratory tests (such as blood tests, tumor marker tests), and tissue biopsies. By analyzing the patient's symptoms, medical history, and test results, doctors can assess the presence and type of cancer and develop personalized treatment plans. Early detection can significantly improve cure and survival rates and promote overall health management for patients.
This report is a detailed and comprehensive analysis for global Tumor Detection Services market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Tumor Detection Services market size and forecasts, in consumption value ($ Million), 2021-2032
Global Tumor Detection Services market size and forecasts by region and country, in consumption value ($ Million), 2021-2032
Global Tumor Detection Services market size and forecasts, by Type and by Application, in consumption value ($ Million), 2021-2032
Global Tumor Detection Services market shares of main players, in revenue ($ Million), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Tumor Detection Services
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Tumor Detection Services market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Nonacus, Natera, Penn Medicine, Amadix, Oncologica, Rarecells, GRAIL, Elypta, Bio-Techne, iCAD, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market segmentation
Tumor Detection Services market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Non-Invasive Examination
Invasive Examination
Market segment by Application
Adults
Children
Market segment by players, this report covers
Nonacus
Natera
Penn Medicine
Amadix
Oncologica
Rarecells
GRAIL
Elypta
Bio-Techne
iCAD
Dxcover
Caris Life Sciences
Novocure
Circulogene
Guardant Health
Veracyte
Haystack Oncology
Foundation Medicine
Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Tumor Detection Services product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Tumor Detection Services, with revenue, gross margin, and global market share of Tumor Detection Services from 2021 to 2026.
Chapter 3, the Tumor Detection Services competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2021 to 2032.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2021 to 2026.and Tumor Detection Services market forecast, by regions, by Type and by Application, with consumption value, from 2027 to 2032.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Tumor Detection Services.
Chapter 13, to describe Tumor Detection Services research findings and conclusion.


1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Classification of Tumor Detection Services by Type
    • 1.3.1 Overview: Global Tumor Detection Services Market Size by Type: 2021 Versus 2025 Versus 2032
    • 1.3.2 Global Tumor Detection Services Consumption Value Market Share by Type in 2025
    • 1.3.3 Non-Invasive Examination
    • 1.3.4 Invasive Examination
  • 1.4 Global Tumor Detection Services Market by Application
    • 1.4.1 Overview: Global Tumor Detection Services Market Size by Application: 2021 Versus 2025 Versus 2032
    • 1.4.2 Adults
    • 1.4.3 Children
  • 1.5 Global Tumor Detection Services Market Size & Forecast
  • 1.6 Global Tumor Detection Services Market Size and Forecast by Region
    • 1.6.1 Global Tumor Detection Services Market Size by Region: 2021 VS 2025 VS 2032
    • 1.6.2 Global Tumor Detection Services Market Size by Region, (2021-2032)
    • 1.6.3 North America Tumor Detection Services Market Size and Prospect (2021-2032)
    • 1.6.4 Europe Tumor Detection Services Market Size and Prospect (2021-2032)
    • 1.6.5 Asia-Pacific Tumor Detection Services Market Size and Prospect (2021-2032)
    • 1.6.6 South America Tumor Detection Services Market Size and Prospect (2021-2032)
    • 1.6.7 Middle East & Africa Tumor Detection Services Market Size and Prospect (2021-2032)

2 Company Profiles

  • 2.1 Nonacus
    • 2.1.1 Nonacus Details
    • 2.1.2 Nonacus Major Business
    • 2.1.3 Nonacus Tumor Detection Services Product and Solutions
    • 2.1.4 Nonacus Tumor Detection Services Revenue, Gross Margin and Market Share (2021-2026)
    • 2.1.5 Nonacus Recent Developments and Future Plans
  • 2.2 Natera
    • 2.2.1 Natera Details
    • 2.2.2 Natera Major Business
    • 2.2.3 Natera Tumor Detection Services Product and Solutions
    • 2.2.4 Natera Tumor Detection Services Revenue, Gross Margin and Market Share (2021-2026)
    • 2.2.5 Natera Recent Developments and Future Plans
  • 2.3 Penn Medicine
    • 2.3.1 Penn Medicine Details
    • 2.3.2 Penn Medicine Major Business
    • 2.3.3 Penn Medicine Tumor Detection Services Product and Solutions
    • 2.3.4 Penn Medicine Tumor Detection Services Revenue, Gross Margin and Market Share (2021-2026)
    • 2.3.5 Penn Medicine Recent Developments and Future Plans
  • 2.4 Amadix
    • 2.4.1 Amadix Details
    • 2.4.2 Amadix Major Business
    • 2.4.3 Amadix Tumor Detection Services Product and Solutions
    • 2.4.4 Amadix Tumor Detection Services Revenue, Gross Margin and Market Share (2021-2026)
    • 2.4.5 Amadix Recent Developments and Future Plans
  • 2.5 Oncologica
    • 2.5.1 Oncologica Details
    • 2.5.2 Oncologica Major Business
    • 2.5.3 Oncologica Tumor Detection Services Product and Solutions
    • 2.5.4 Oncologica Tumor Detection Services Revenue, Gross Margin and Market Share (2021-2026)
    • 2.5.5 Oncologica Recent Developments and Future Plans
  • 2.6 Rarecells
    • 2.6.1 Rarecells Details
    • 2.6.2 Rarecells Major Business
    • 2.6.3 Rarecells Tumor Detection Services Product and Solutions
    • 2.6.4 Rarecells Tumor Detection Services Revenue, Gross Margin and Market Share (2021-2026)
    • 2.6.5 Rarecells Recent Developments and Future Plans
  • 2.7 GRAIL
    • 2.7.1 GRAIL Details
    • 2.7.2 GRAIL Major Business
    • 2.7.3 GRAIL Tumor Detection Services Product and Solutions
    • 2.7.4 GRAIL Tumor Detection Services Revenue, Gross Margin and Market Share (2021-2026)
    • 2.7.5 GRAIL Recent Developments and Future Plans
  • 2.8 Elypta
    • 2.8.1 Elypta Details
    • 2.8.2 Elypta Major Business
    • 2.8.3 Elypta Tumor Detection Services Product and Solutions
    • 2.8.4 Elypta Tumor Detection Services Revenue, Gross Margin and Market Share (2021-2026)
    • 2.8.5 Elypta Recent Developments and Future Plans
  • 2.9 Bio-Techne
    • 2.9.1 Bio-Techne Details
    • 2.9.2 Bio-Techne Major Business
    • 2.9.3 Bio-Techne Tumor Detection Services Product and Solutions
    • 2.9.4 Bio-Techne Tumor Detection Services Revenue, Gross Margin and Market Share (2021-2026)
    • 2.9.5 Bio-Techne Recent Developments and Future Plans
  • 2.10 iCAD
    • 2.10.1 iCAD Details
    • 2.10.2 iCAD Major Business
    • 2.10.3 iCAD Tumor Detection Services Product and Solutions
    • 2.10.4 iCAD Tumor Detection Services Revenue, Gross Margin and Market Share (2021-2026)
    • 2.10.5 iCAD Recent Developments and Future Plans
  • 2.11 Dxcover
    • 2.11.1 Dxcover Details
    • 2.11.2 Dxcover Major Business
    • 2.11.3 Dxcover Tumor Detection Services Product and Solutions
    • 2.11.4 Dxcover Tumor Detection Services Revenue, Gross Margin and Market Share (2021-2026)
    • 2.11.5 Dxcover Recent Developments and Future Plans
  • 2.12 Caris Life Sciences
    • 2.12.1 Caris Life Sciences Details
    • 2.12.2 Caris Life Sciences Major Business
    • 2.12.3 Caris Life Sciences Tumor Detection Services Product and Solutions
    • 2.12.4 Caris Life Sciences Tumor Detection Services Revenue, Gross Margin and Market Share (2021-2026)
    • 2.12.5 Caris Life Sciences Recent Developments and Future Plans
  • 2.13 Novocure
    • 2.13.1 Novocure Details
    • 2.13.2 Novocure Major Business
    • 2.13.3 Novocure Tumor Detection Services Product and Solutions
    • 2.13.4 Novocure Tumor Detection Services Revenue, Gross Margin and Market Share (2021-2026)
    • 2.13.5 Novocure Recent Developments and Future Plans
  • 2.14 Circulogene
    • 2.14.1 Circulogene Details
    • 2.14.2 Circulogene Major Business
    • 2.14.3 Circulogene Tumor Detection Services Product and Solutions
    • 2.14.4 Circulogene Tumor Detection Services Revenue, Gross Margin and Market Share (2021-2026)
    • 2.14.5 Circulogene Recent Developments and Future Plans
  • 2.15 Guardant Health
    • 2.15.1 Guardant Health Details
    • 2.15.2 Guardant Health Major Business
    • 2.15.3 Guardant Health Tumor Detection Services Product and Solutions
    • 2.15.4 Guardant Health Tumor Detection Services Revenue, Gross Margin and Market Share (2021-2026)
    • 2.15.5 Guardant Health Recent Developments and Future Plans
  • 2.16 Veracyte
    • 2.16.1 Veracyte Details
    • 2.16.2 Veracyte Major Business
    • 2.16.3 Veracyte Tumor Detection Services Product and Solutions
    • 2.16.4 Veracyte Tumor Detection Services Revenue, Gross Margin and Market Share (2021-2026)
    • 2.16.5 Veracyte Recent Developments and Future Plans
  • 2.17 Haystack Oncology
    • 2.17.1 Haystack Oncology Details
    • 2.17.2 Haystack Oncology Major Business
    • 2.17.3 Haystack Oncology Tumor Detection Services Product and Solutions
    • 2.17.4 Haystack Oncology Tumor Detection Services Revenue, Gross Margin and Market Share (2021-2026)
    • 2.17.5 Haystack Oncology Recent Developments and Future Plans
  • 2.18 Foundation Medicine
    • 2.18.1 Foundation Medicine Details
    • 2.18.2 Foundation Medicine Major Business
    • 2.18.3 Foundation Medicine Tumor Detection Services Product and Solutions
    • 2.18.4 Foundation Medicine Tumor Detection Services Revenue, Gross Margin and Market Share (2021-2026)
    • 2.18.5 Foundation Medicine Recent Developments and Future Plans

3 Market Competition, by Players

  • 3.1 Global Tumor Detection Services Revenue and Share by Players (2021-2026)
  • 3.2 Market Share Analysis (2025)
    • 3.2.1 Market Share of Tumor Detection Services by Company Revenue
    • 3.2.2 Top 3 Tumor Detection Services Players Market Share in 2025
    • 3.2.3 Top 6 Tumor Detection Services Players Market Share in 2025
  • 3.3 Tumor Detection Services Market: Overall Company Footprint Analysis
    • 3.3.1 Tumor Detection Services Market: Region Footprint
    • 3.3.2 Tumor Detection Services Market: Company Product Type Footprint
    • 3.3.3 Tumor Detection Services Market: Company Product Application Footprint
  • 3.4 New Market Entrants and Barriers to Market Entry
  • 3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type

  • 4.1 Global Tumor Detection Services Consumption Value and Market Share by Type (2021-2026)
  • 4.2 Global Tumor Detection Services Market Forecast by Type (2027-2032)

5 Market Size Segment by Application

  • 5.1 Global Tumor Detection Services Consumption Value Market Share by Application (2021-2026)
  • 5.2 Global Tumor Detection Services Market Forecast by Application (2027-2032)

6 North America

  • 6.1 North America Tumor Detection Services Consumption Value by Type (2021-2032)
  • 6.2 North America Tumor Detection Services Market Size by Application (2021-2032)
  • 6.3 North America Tumor Detection Services Market Size by Country
    • 6.3.1 North America Tumor Detection Services Consumption Value by Country (2021-2032)
    • 6.3.2 United States Tumor Detection Services Market Size and Forecast (2021-2032)
    • 6.3.3 Canada Tumor Detection Services Market Size and Forecast (2021-2032)
    • 6.3.4 Mexico Tumor Detection Services Market Size and Forecast (2021-2032)

7 Europe

  • 7.1 Europe Tumor Detection Services Consumption Value by Type (2021-2032)
  • 7.2 Europe Tumor Detection Services Consumption Value by Application (2021-2032)
  • 7.3 Europe Tumor Detection Services Market Size by Country
    • 7.3.1 Europe Tumor Detection Services Consumption Value by Country (2021-2032)
    • 7.3.2 Germany Tumor Detection Services Market Size and Forecast (2021-2032)
    • 7.3.3 France Tumor Detection Services Market Size and Forecast (2021-2032)
    • 7.3.4 United Kingdom Tumor Detection Services Market Size and Forecast (2021-2032)
    • 7.3.5 Russia Tumor Detection Services Market Size and Forecast (2021-2032)
    • 7.3.6 Italy Tumor Detection Services Market Size and Forecast (2021-2032)

8 Asia-Pacific

  • 8.1 Asia-Pacific Tumor Detection Services Consumption Value by Type (2021-2032)
  • 8.2 Asia-Pacific Tumor Detection Services Consumption Value by Application (2021-2032)
  • 8.3 Asia-Pacific Tumor Detection Services Market Size by Region
    • 8.3.1 Asia-Pacific Tumor Detection Services Consumption Value by Region (2021-2032)
    • 8.3.2 China Tumor Detection Services Market Size and Forecast (2021-2032)
    • 8.3.3 Japan Tumor Detection Services Market Size and Forecast (2021-2032)
    • 8.3.4 South Korea Tumor Detection Services Market Size and Forecast (2021-2032)
    • 8.3.5 India Tumor Detection Services Market Size and Forecast (2021-2032)
    • 8.3.6 Southeast Asia Tumor Detection Services Market Size and Forecast (2021-2032)
    • 8.3.7 Australia Tumor Detection Services Market Size and Forecast (2021-2032)

9 South America

  • 9.1 South America Tumor Detection Services Consumption Value by Type (2021-2032)
  • 9.2 South America Tumor Detection Services Consumption Value by Application (2021-2032)
  • 9.3 South America Tumor Detection Services Market Size by Country
    • 9.3.1 South America Tumor Detection Services Consumption Value by Country (2021-2032)
    • 9.3.2 Brazil Tumor Detection Services Market Size and Forecast (2021-2032)
    • 9.3.3 Argentina Tumor Detection Services Market Size and Forecast (2021-2032)

10 Middle East & Africa

  • 10.1 Middle East & Africa Tumor Detection Services Consumption Value by Type (2021-2032)
  • 10.2 Middle East & Africa Tumor Detection Services Consumption Value by Application (2021-2032)
  • 10.3 Middle East & Africa Tumor Detection Services Market Size by Country
    • 10.3.1 Middle East & Africa Tumor Detection Services Consumption Value by Country (2021-2032)
    • 10.3.2 Turkey Tumor Detection Services Market Size and Forecast (2021-2032)
    • 10.3.3 Saudi Arabia Tumor Detection Services Market Size and Forecast (2021-2032)
    • 10.3.4 UAE Tumor Detection Services Market Size and Forecast (2021-2032)

11 Market Dynamics

  • 11.1 Tumor Detection Services Market Drivers
  • 11.2 Tumor Detection Services Market Restraints
  • 11.3 Tumor Detection Services Trends Analysis
  • 11.4 Porters Five Forces Analysis
    • 11.4.1 Threat of New Entrants
    • 11.4.2 Bargaining Power of Suppliers
    • 11.4.3 Bargaining Power of Buyers
    • 11.4.4 Threat of Substitutes
    • 11.4.5 Competitive Rivalry

12 Industry Chain Analysis

  • 12.1 Tumor Detection Services Industry Chain
  • 12.2 Tumor Detection Services Upstream Analysis
  • 12.3 Tumor Detection Services Midstream Analysis
  • 12.4 Tumor Detection Services Downstream Analysis

13 Research Findings and Conclusion

    14 Appendix

    • 14.1 Methodology
    • 14.2 Research Process and Data Source

    Summary:
    Get latest Market Research Reports on Tumor Detection Services. Industry analysis & Market Report on Tumor Detection Services is a syndicated market report, published as Global Tumor Detection Services Market 2026 by Company, Regions, Type and Application, Forecast to 2032. It is complete Research Study and Industry Analysis of Tumor Detection Services market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    		$3,480.00
    		$5,220.00
    		$6,960.00
    		2,690.04
    		4,035.06
    		5,380.08
    		3,239.88
    		4,859.82
    		6,479.76
    		531,361.20
    		797,041.80
    		1,062,722.40
    		293,712.00
    		440,568.00
    		587,424.00
    Credit card Logo
    Sample Question Discount Download PDF

    Related Reports

    Reason to Buy

    • Trusted By Leaders

      Top executives from leading companies purchase research reports from us. 

    • Shop With Confidence

      We assist you with all the pre-sales enquiries related to any report so that you can buy with confidence.

    • Customer Centric

      Need assistance related to your research requirements? We are just a phone call or an email away.

    • Personalized Solutions

      Our experienced research specialists are here to help you locate the right reports for your need.

    • Secure Checkout

      Shop without being worried about safety & security of your transactions.
      •

    Request for Sample of this report

    Reports and Markets

    mcafree

    Contact Us

    +1-352-353-0818 (US)

    info@reportsandmarkets.com

    Support

    EMAIL US

    Newsletter

    KEEP UP TO DATE ON ALL THE LATEST REPORTS


    maxmind_logo